Lisata Therapeutics (LSTA) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $4.6 million.
- Lisata Therapeutics' Total Liabilities fell 258.24% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year decrease of 258.24%. This contributed to the annual value of $5.7 million for FY2024, which is 1639.71% down from last year.
- Lisata Therapeutics' Total Liabilities amounted to $4.6 million in Q3 2025, which was down 258.24% from $4.4 million recorded in Q2 2025.
- Lisata Therapeutics' Total Liabilities' 5-year high stood at $6.8 million during Q4 2023, with a 5-year trough of $3.9 million in Q1 2025.
- Its 3-year average for Total Liabilities is $5.1 million, with a median of $4.8 million in 2024.
- As far as peak fluctuations go, Lisata Therapeutics' Total Liabilities crashed by 161.26% in 2024, and later tumbled by 2943.42% in 2025.
- Over the past 3 years, Lisata Therapeutics' Total Liabilities (Quarter) stood at $6.8 million in 2023, then dropped by 16.4% to $5.7 million in 2024, then dropped by 18.38% to $4.6 million in 2025.
- Its last three reported values are $4.6 million in Q3 2025, $4.4 million for Q2 2025, and $3.9 million during Q1 2025.